ETMarkets.comJB Pharma on Wednesday said its net profit rose 4% year-on-year (YoY) to Rs 88 crore for the fourth quarter ended March 31, 2023.
The PE firm KKR-backed company had reported net Rs 85 crore in the January-March quarter of 2021-22 fiscal.
The net profit was impacted for the quarter primarily due to Rs 14 crore rise in finance cost on term loan for brand acquisitions.
Revenue grew 22% YoY to Rs 762 crores in Q4FY23. Operating earnings before interest, depreciation and tax increased by 21% to Rs 181 crores.
Operating cash flow improved in FY23 to Rs 626 crores as compared to Rs 170 crores in FY22, strongly aided by the higher proportion of India business and a strong focus on working capital management, which includes inventory and receivables.
Domestic business revenue grew 29% YoY to Rs 380 crores in Q4FY23.JB Pharma grew 30% for Q4 FY23, double the industry growth rate of 15%.
As per IQVIA Mar 2023 data, all 6 top brands of JB Pharma gained ranks.
International business grew by 16% to Rs 382 crores in Q4FY23 led by demand revival in Russia, South Africa private business and strong momentum of contract manufacturing business
The PE firm KKR-backed company had reported net Rs 85 crore in the January-March quarter of 2021-22 fiscal.
The net profit was impacted for the quarter primarily due to Rs 14 crore rise in finance cost on term loan for brand acquisitions.
Revenue grew 22% YoY to Rs 762 crores in Q4FY23. Operating earnings before interest, depreciation and tax increased by 21% to Rs 181 crores.
Operating cash flow improved in FY23 to Rs 626 crores as compared to Rs 170 crores in FY22, strongly aided by the higher proportion of India business and a strong focus on working capital management, which includes inventory and receivables.
Domestic business revenue grew 29% YoY to Rs 380 crores in Q4FY23.JB Pharma grew 30% for Q4 FY23, double the industry growth rate of 15%.
As per IQVIA Mar 2023 data, all 6 top brands of JB Pharma gained ranks.
International business grew by 16% to Rs 382 crores in Q4FY23 led by demand revival in Russia, South Africa private business and strong momentum of contract manufacturing business
Wednesday, 24 May, 2023Experience Your Economic Times Newspaper, The Digital Way!
- Front Page
- Pure Politics
- Companies
- Around the World
- More
GQG Looks to Invest $1b More in AdaniInvestment firm GQG Partners is in talks for an additional investment of around $1 billion in Adani Group shares, having reaped bumper returns on the close to $2 billion it ploughed into the conglomerate’s stocks in March, said people with knowledge of the matter.
Adani Green to Seek Board Nod to Raise up to $1bAdani Green Energy is set to seek board approval to raise ₹6,150 crore ($750 million) to ₹8,200 crore ($1 billion) through the qualified institutional placement (QIP) route, said people aware of the matter.
A Public-Private Divide on Day 1 of Note ExchangeOn the first day for exchanging ₹2,000 banknotes, some banks insisted people provide identity proofs while depositing or swapping the recalled legal tender even as some other lenders did not.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share PricePick the best stocks for yourself
Powered by 
Get Unlimited Access to The Economic Times 
